Data monitoring committees - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document deals with independent data monitoring committees. It highlights the key issues involved when sponsors include data monitoring committees as a part of their trial management.
Keywords: Safety monitoring, benefit/risk assessment, interim analysis, futility, type 1 error control, study integrity, study conduct
